Stock listing
NASDAQ:PHAR Pharming Group NV Stock
US listing (NASDAQ) of Pharming Group NV · home listing Euronext:PHARM
Follow Pharming Group NV into a list and get an email when it puts out news.
Share price · NASDAQ:PHAR
$12.06 USD -0.53 (-4.2%)
Close on Nov 17, 2026
- Day range
- $12.06 – $12.35 USDNov 17, 2026
- Volume
- 8,319 sharesNov 17, 2026
- Market cap
- $853.6M USDAt the close on Nov 17, 2026 · price × 70.78M shares outstanding
- 52-week range
- $9.11 – $21.34 USDLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- $251,744 USDMedian day 15,300 shares · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:PHARM · Home | €1.117 EUR | -0.004 (-0.4%) | 4,519,835 | €1.12 | €1.134 | €1.113 | €1.122 | Close on Nov 18, 2026 |
| NASDAQ:PHAR | $12.06 USD | -0.53 (-4.2%) | 8,319 | $12.26 | $12.35 | $12.06 | $12.59 | Close on Nov 17, 2026 |
| OTC:PHGUF | $1.26 USD | 0.00 (0.0%) | — | $1.26 | $1.26 | $1.26 | $1.26 | Close on Nov 6, 2026 |
| Frankfurt:PHG | €10.90 EUR | -0.30 (-2.7%) | — | €10.90 | €11.10 | €10.90 | €11.20 | Close on Nov 17, 2026 |
| Stuttgart:PHGN | €1.068 EUR | -0.038 (-3.4%) | 2,437 | €1.103 | €1.132 | €1.068 | €1.106 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · NASDAQ:PHAR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.29 | -0.01 | -0.1% | $12.05 | $12.38 | $12.05 | 9,700 | |
| $12.30 | -0.16 | -1.3% | $12.40 | $12.72 | $12.13 | 12,600 | |
| $12.46 | -0.47 | -3.6% | $12.78 | $13.14 | $12.14 | 26,900 | |
| $12.93 | +0.20 | +1.6% | $12.69 | $13.00 | $12.45 | 21,600 | |
| $12.73 | +0.50 | +4.1% | $12.75 | $12.75 | $12.46 | 19,900 | |
| $12.23 | +0.10 | +0.8% | $12.20 | $12.31 | $12.09 | 14,000 | |
| $12.13 | -0.13 | -1.1% | $12.25 | $12.27 | $11.75 | 12,400 | |
| $12.26 | +0.39 | +3.3% | $11.85 | $12.28 | $11.85 | 29,000 | |
| $11.87 | -0.03 | -0.3% | $12.01 | $12.19 | $11.77 | 19,200 | |
| $11.90 | +0.70 | +6.3% | $11.55 | $11.92 | $11.55 | 43,400 | |
| $11.20 | +0.53 | +5.0% | $11.32 | $11.45 | $10.76 | 25,800 | |
| $10.67 | +1.02 | +10.6% | $10.57 | $10.80 | $10.55 | 21,600 | |
| $9.65 | -0.10 | -1.0% | $9.47 | $9.73 | $9.45 | 10,900 | |
| $9.75 | +0.64 | +7.0% | $9.39 | $9.77 | $9.341 | 6,300 | |
| $9.11 | -0.25 | -2.7% | $9.315 | $9.34 | $9.11 | 13,400 | |
| $9.36 | -0.27 | -2.8% | $9.50 | $9.515 | $9.31 | 9,000 | |
| $9.63 | -0.01 | -0.1% | $9.50 | $10.03 | $9.50 | 7,300 | |
| $9.64 | +0.20 | +2.1% | $9.55 | $9.64 | $9.49 | 3,900 | |
| $9.44 | -0.17 | -1.8% | $9.62 | $9.62 | $9.32 | 28,900 | |
| $9.61 | -0.18 | -1.8% | $9.90 | $9.90 | $9.561 | 7,500 | |
| $9.79 | +0.26 | +2.7% | $9.79 | $9.85 | $9.525 | 3,300 | |
| $9.53 | -0.12 | -1.2% | $9.65 | $9.772 | $9.441 | 5,100 | |
| $9.65 | -0.03 | -0.3% | $9.65 | $9.75 | $9.59 | 3,800 | |
| $9.68 | -0.12 | -1.2% | $9.86 | $9.86 | $9.68 | 6,700 | |
| $9.80 | +0.05 | +0.5% | $9.75 | $10.08 | $9.736 | 10,800 | |
| $9.75 | -0.20 | -2.0% | $9.95 | $9.959 | $9.75 | 12,200 | |
| $9.95 | -0.04 | -0.4% | $10.08 | $10.15 | $9.95 | 12,100 | |
| $9.99 | -0.02 | -0.2% | $10.16 | $10.28 | $9.99 | 12,300 | |
| $10.01 | -0.51 | -4.8% | $10.17 | $10.23 | $10.00 | 26,300 | |
| $10.52 | +0.06 | +0.6% | $10.46 | $10.70 | $10.33 | 15,500 | |
| $10.46 | +0.02 | +0.2% | $10.42 | $11.15 | $10.25 | 128,500 | |
| $10.44 | -0.33 | -3.1% | $10.59 | $10.64 | $10.36 | 31,700 | |
| $10.77 | -0.49 | -4.4% | $11.00 | $11.06 | $10.65 | 28,600 | |
| $11.26 | +0.45 | +4.2% | $11.11 | $11.48 | $10.99 | 51,300 | |
| $10.81 | +0.26 | +2.5% | $10.50 | $11.50 | $10.50 | 217,300 | |
| $10.55 | -0.23 | -2.1% | $10.72 | $10.75 | $10.50 | 7,900 | |
| $10.78 | +0.18 | +1.7% | $10.73 | $10.95 | $10.73 | 5,400 | |
| $10.60 | +0.05 | +0.5% | $10.67 | $10.75 | $10.50 | 58,000 | |
| $10.55 | -0.27 | -2.5% | $10.82 | $10.83 | $10.44 | 15,300 | |
| $10.82 | -0.39 | -3.5% | $10.78 | $11.19 | $10.72 | 19,600 | |
| $11.21 | +0.405 | +3.7% | $10.82 | $11.69 | $10.65 | 39,100 | |
| $10.81 | -0.165 | -1.5% | $10.91 | $10.97 | $10.67 | 15,300 | |
| $10.97 | -0.53 | -4.6% | $11.15 | $11.54 | $10.97 | 12,100 | |
| $11.50 | +0.27 | +2.4% | $11.38 | $11.50 | $11.30 | 21,500 | |
| $11.23 | -0.23 | -2.0% | $11.16 | $11.54 | $11.16 | 5,500 | |
| $11.46 | +0.26 | +2.3% | $11.38 | $11.48 | $11.31 | 5,400 | |
| $11.20 | +0.09 | +0.8% | $11.51 | $11.55 | $11.20 | 5,000 | |
| $11.11 | -0.37 | -3.2% | $11.36 | $11.59 | $11.03 | 34,500 | |
| $11.48 | -0.22 | -1.9% | $11.50 | $11.66 | $11.48 | 12,400 | |
| $11.70 | -0.08 | -0.7% | $11.81 | $11.81 | $11.63 | 9,400 | |
| $11.78 | -0.17 | -1.4% | $11.84 | $11.96 | $11.77 | 6,400 | |
| $11.95 | +0.18 | +1.5% | $11.86 | $12.32 | $11.72 | 35,500 | |
| $11.77 | +0.31 | +2.7% | $11.67 | $11.96 | $11.67 | 21,500 | |
| $11.46 | -0.39 | -3.3% | $11.62 | $12.21 | $11.45 | 23,200 | |
| $11.85 | +0.17 | +1.5% | $11.76 | $11.97 | $11.73 | 11,000 | |
| $11.68 | -0.17 | -1.4% | $11.84 | $12.03 | $11.68 | 18,000 | |
| $11.85 | -0.06 | -0.5% | $11.89 | $12.05 | $11.68 | 17,200 | |
| $11.91 | +0.12 | +1.0% | $11.65 | $11.91 | $11.50 | 22,000 | |
| $11.79 | +0.07 | +0.6% | $11.72 | $12.12 | $11.72 | 17,300 |
- Ticker
- NASDAQ:PHAR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Latest earnings call · Jul 30, 2026
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 40 slides
Calls
Replays
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 8:30 AM ET
Watch Transcript
Latest news
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Nov 6, 2026
Closed $12.29 (-0.1%) on Nov 6, 2026
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
Oct 27, 2026
Closed $11.87 (-0.3%) on Oct 27, 2026
Pharming Group announces third quarter 2026 revenues above market expectations
Oct 22, 2026
Closed $10.67 (+10.6%) on Oct 22, 2026
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
Oct 14, 2026
Closed $9.64 (+2.1%) on Oct 14, 2026
Pharming announces CEO transition
Sep 29, 2026
Closed $10.01 (-4.8%) on Sep 29, 2026
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
Sep 25, 2026
Closed $10.46 (+0.2%) on Sep 25, 2026
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
Sep 22, 2026
Closed $11.26 (+4.2%) on Sep 22, 2026
FDA approves Pharming's Joenja(R) as first treatment for children with APDS in the U.S.
Sep 14, 2026
Closed $10.82 (-3.5%) on Sep 14, 2026
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
Sep 11, 2026
Closed $11.21 (+3.7%) on Sep 11, 2026
Pharming Group to participate in September investor conferences
Sep 9, 2026
Closed $10.97 (-4.6%) on Sep 9, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 40 slides · November 2026
Q3 2026 Earnings Presentation
Earnings · 32 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 41 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
Pharming Group NV on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 55 in all · newest Nov 6, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Jul 30, 2026
- Decks
- 85 decks · latest November 2026
Where Pharming Group NV is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:PHARM · Home listing | Euronext | Netherlands | EUR |
| NASDAQ:PHAR · This page | NASDAQ | United States | USD |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| LSIN:0QCO | LSIN | United Kingdom | EUR |
| gettex:PHGN | gettex | Germany | EUR |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| Tradegate:PHGN | Tradegate | Germany | EUR |
| Xetra:PHGN | Xetra | Germany | EUR |
| LS Exchange:A1H65A | LS Exchange | Germany | EUR |
| OTC:PHGUF | OTC | United States | USD |
| BOATS:PHAR | BOATS | United States | USD |
| Turquoise:PHARMA | Turquoise | United Kingdom | EUR |
| gettex:PHG | gettex | Germany | EUR |
| Lang & Schwarz:A1H65A | Lang & Schwarz | Germany | EUR |
| Frankfurt:PHGN | Frankfurt | Germany | EUR |
| Hamburg:PHGN | Hamburg | Germany | EUR |
| Stuttgart:PHG | Stuttgart | Germany | EUR |
| BX Swiss:PHGN | BX Swiss | Switzerland | CHF |
| Dusseldorf:PHGN | Dusseldorf | Germany | EUR |
| Frankfurt:PHG | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QLQY | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QLQY | LS Exchange | Germany | EUR |
| Munich:PHGN | Munich | Germany | EUR |
| Dusseldorf:PHG | Dusseldorf | Germany | EUR |
| Munich:PHG | Munich | Germany | EUR |
| Stuttgart:PHGN | Stuttgart | Germany | EUR |
| Hanover:PHGN | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Pharming Group NV.